Lee‐Fong Yau

1.0k citations
42 papers · 829 indexed · h-index 16
Topics
Natural product bioactivities and synthesis (10 papers)Glycosylation and Glycoproteins Research (7 papers)Ginseng Biological Effects and Applications (6 papers)
Partner nations
MacaoChinaHong Kong

In The Last Decade

Lee‐Fong Yau

40 papers receiving 822 citations

Peers

Lee‐Fong Yau
Comparison fields: 5 of 94
  • Molecular Biology 534
  • Pharmacology 137
  • Complementary and alternative medicine 130
  • Pharmacology 75
  • Immunology 67
Replace Yihang Shen with:
Yihang Shen China
Zhongxiang Zhao China
Xiaolan Wu China
Yamei Li China
Wen Tan China
Byeol Ryu South Korea
Shoude Zhang China
Dejuan Sun China
Guangbo Ge China
Ruowen Zhang China
Lee‐Fong Yau relative to Yihang Shen China Yihang Shen's profile →
Citations per field
00.5×10×20×28.5×
Yihang Shen · 1×
Citations per year

Countries citing papers authored by Lee‐Fong Yau

Since Specialization
Citations

This map shows the geographic impact of Lee‐Fong Yau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee‐Fong Yau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee‐Fong Yau more than expected).

Fields of papers citing papers by Lee‐Fong Yau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee‐Fong Yau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee‐Fong Yau. The network helps show where Lee‐Fong Yau may publish in the future.

Co-authorship network of co-authors of Lee‐Fong Yau

This figure shows the co-authorship network connecting the top 25 collaborators of Lee‐Fong Yau. A scholar is included among the top collaborators of Lee‐Fong Yau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee‐Fong Yau. Lee‐Fong Yau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 6
4 13
5 2
6 4
7 4
8 9
9 7
10 10
11 7
12 9
13 32
14 95
15 11
16 22
17 43
18 28
19 19
20 28

About Lee‐Fong Yau

Lee‐Fong Yau is a scholar working on Complementary and alternative medicine, Pharmacology and Molecular Biology, having authored 42 papers that have together received 829 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Ginseng Biological Effects and Applications (6 papers). The work is most often cited by research in Complementary and alternative medicine (130 citations), Pharmacology (137 citations) and Molecular Biology (534 citations). Lee‐Fong Yau has collaborated with scholars based in Macao, China and Hong Kong. Frequent co-authors include Zhi‐Hong Jiang, Jingrong Wang, Weina Gao, Liang Liu, Liang Liu, Tian‐Tian Tong, Ping Hu, Hao Huang, Jianing Mi and Zhongzhen Zhao. Their work appears in journals such as Nature Communications, Analytical Chemistry and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026